L-Ent-oxPt(IV) | MedChemExpress (MCE)
L-Ent-oxPt IV (L-EOP) is a Oxaliplatin (HY-17371)-based siderophore-platinum conjugate. L-Ent-oxPt IV exhibits selectivity towards Escherichia coli and antibacterial activity through DNA damage[1].
| Trivial name | L-Ent-oxPt(IV) |
| Catalog Number | HY-163383 |
| Alternative Name(s) | L-EOP |
| Research Area | Infection |
| Purity | ≥98.0% |
| SMILES | CC(O[Pt]1(OC2=O)(OC2=O)(OC(CCC3=CN(CCOCCOCCOCCNC(C4=CC(C(N[C@@H](CO5)C(OC[C@@H](C(OC[C@H](NC(C6=C(O)C(O)=CC=C6)=O)C5=O)=O)NC(C7=C(O)C(O)=CC=C7)=O)=O)=O)=C(O)C(O)=C4)=O)N=N3)=O)[NH2][C@@H]8CCCC[C@H]8[NH2]1)=O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/l-ent-oxpt-iv.html |